Cobblestone Capital Advisors LLC NY Has $992,000 Position in UnitedHealth Group Incorporated $UNH

Cobblestone Capital Advisors LLC NY reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 6.7% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,180 shares of the healthcare conglomerate’s stock after selling 230 shares during the quarter. Cobblestone Capital Advisors LLC NY’s holdings in UnitedHealth Group were worth $992,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Brighton Jones LLC grew its position in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after buying an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC grew its position in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after buying an additional 2,324 shares in the last quarter. Elevated Capital Advisors LLC grew its position in UnitedHealth Group by 3.0% during the first quarter. Elevated Capital Advisors LLC now owns 1,186 shares of the healthcare conglomerate’s stock worth $621,000 after buying an additional 35 shares in the last quarter. Capital Advisors Wealth Management LLC grew its position in UnitedHealth Group by 10.8% during the first quarter. Capital Advisors Wealth Management LLC now owns 658 shares of the healthcare conglomerate’s stock worth $345,000 after buying an additional 64 shares in the last quarter. Finally, Guardian Asset Advisors LLC acquired a new stake in UnitedHealth Group during the first quarter worth about $201,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

UNH stock opened at $362.78 on Monday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The company has a 50 day moving average price of $338.43 and a 200 day moving average price of $335.78. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The stock has a market capitalization of $328.56 billion, a PE ratio of 15.72, a price-to-earnings-growth ratio of 2.34 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter last year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on UNH shares. Sanford C. Bernstein lifted their target price on UnitedHealth Group from $379.00 to $433.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 8th. UBS Group restated a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. The Goldman Sachs Group began coverage on shares of UnitedHealth Group in a research note on Tuesday, October 14th. They set a “buy” rating and a $406.00 price target for the company. Morgan Stanley raised their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. Finally, Wells Fargo & Company raised their price target on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Eighteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $385.13.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.